NEDD1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.245800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.082580E-01
Normal-vs-Stage2
1.124560E-01
Normal-vs-Stage3
1.515820E-02
Normal-vs-Stage4
4.016600E-01
Stage1-vs-Stage2
9.187400E-01
Stage1-vs-Stage3
9.159800E-02
Stage1-vs-Stage4
4.600600E-01
Stage2-vs-Stage3
1.238640E-01
Stage2-vs-Stage4
5.083800E-01
Stage3-vs-Stage4
5.182000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.560000E-02
Normal-vs-AfricanAmerican
2.175000E-01
Normal-vs-Asian
3.652100E-02
Caucasian-vs-AfricanAmerican
9.393600E-01
Caucasian-vs-Asian
2.565800E-01
AfricanAmerican-vs-Asian
5.183400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.391820E-01
Normal-vs-Female
4.946200E-02
Male-vs-Female
9.986400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.031160E-01
Normal-vs-Age(41-60Yrs)
2.963800E-01
Normal-vs-Age(61-80Yrs)
4.087900E-02
Normal-vs-Age(81-100Yrs)
1.243350E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.096400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.192400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.196800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.131740E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.666400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.283800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.961990E-02
Normal-vs-Daily Drinker
2.533800E-02
Normal-vs-Weekly Drinker
1.867750E-02
Normal-vs-Occasional Drinker
5.083200E-01
Normal-vs-Social Drinker
2.428400E-01
Non Drinker-vs-Daily Drinker
5.550000E-01
Non Drinker-vs-Weekly Drinker
6.504600E-01
Non Drinker-vs-Occasional Drinker
2.006800E-01
Non Drinker-vs-Social Drinker
1.834410E-01
Daily Drinker-vs-Weekly Drinker
9.310600E-01
Daily Drinker-vs-Occasional Drinker
1.239600E-01
Daily Drinker-vs-Social Drinker
1.166970E-01
Weekly Drinker-vs-Occasional Drinker
1.422420E-01
Weekly Drinker-vs-Social Drinker
1.616230E-01
Occasional Drinker-vs-Social Drinker
7.559200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.476800E-01
Normal-vs-Grade 2
1.104970E-01
Normal-vs-Grade 3
8.464100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.405400E-01
Grade 1-vs-Grade 3
8.991600E-02
Grade 1-vs-Grade 4
2.476800E-01
Grade 2-vs-Grade 3
3.639800E-01
Grade 2-vs-Grade 4
1.104970E-01
Grade 3-vs-Grade 4
8.464100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.497500E-02
Normal-vs-NonDiabetic
7.213700E-02
Diabetic-vs-NonDiabetic
8.084600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.938700E-03
Normal-vs-NoPancreatitis
8.735900E-02
Pancreatitis-vs-NoPancreatitis
1.853810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.430300E-02
Normal-vs-N1
1.253000E-01
N0-vs-N1
3.150000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.223000E-01
Normal-vs-TP53-NonMutant
7.078400E-02
TP53-Mutant-vs-TP53-NonMutant
1.568030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
